Bayer's cell therapy for Parkinson's disease is on the brink of a phase 3 trial, while its gene therapy has started phase 2 testing.

Armed with new phase 3 data, Bayer has started preparing filings for elinzanetant as a treatment for vasomotor symptoms (VMS) associated with menopause, setting up a challenge to Astellas’ first ...

Bayer says its glyphosate plant in Luling, La., is back online after being shuttered since August 28. The plant was idled after Hurricane Ida barreled into the Gulf Coast.